Skip to content

Medicare and Senior Benefits

Medicare prescription drug premiums expected to climb in 2027

Digilifetrends Published 1 min read

Millions of Medicare beneficiaries enrolled in stand-alone prescription drug plans are projected to face an average 50% increase in monthly premiums in 2027, according to a new analysis.

That average increase, from $34 a month to $51, can be avoided by switching to less expensive plans during the program’s open enrollment period.

U.S. President Donald Trump, accompanied by, from left, B1 Medicines CEO John Oiler, Astellas Pharma President Michael Putrasis, Commerce Secretary Howard Lutnick, Health and Human Services Secretary Robert F. Kennedy Jr., and Administrator for the Centers for Medicare & Medicaid Services Dr. Mehmet Oz, holds up a poster that displays drug prices as he speaks during a healthcare affordability event in the Oval Office at the White House on Monday, Aug. 31, 2026, in Washington, D.C.
U.S. President Donald Trump, accompanied by, from left, B1 Medicines CEO John Oiler, Astellas Pharma President Michael Putrasis, Commerce Secretary Howard Lutnick, Health and Human Services Secretary Robert F. Kennedy Jr., and Administrator for the Centers for Medicare & Medicaid Services Dr. Mehmet Oz, holds up a poster that displays drug prices as he speaks during a healthcare affordability event in the Oval Office at the White House on Monday, Aug. 31, 2026, in Washington, D.C. (Kevin Dietsch/Getty Images/TNS)

More from Digilifetrends